Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Professor Lisa Stamp

PositionProfessor
DepartmentDepartment of Medicine (UOC)
QualificationsMB ChB FRACP PhD DipMus
Research summaryRheumatology and immunology

Research

  • Pathophysiology of rheumatoid arthritis
  • Soluble markers in early rheumatoid arthritis
  • Pathophysiology and management of gout
  • Wegener's Granulomatosis

Publications

Ton, K. N., Cree, S. L., Gronert-Sum, S. J., Merriman, T. R., Stamp, L. K., & Kennedy, M. A. (2018). Multiplexed nanopore sequencing of HLA-B locus in Māori and Pacific Island samples. Frontiers in Genetics. Advance online publication. doi: 10.3389/fgene.2018.00152

Krishnan, M., Major, T. J., Topless, R. K., Dewes, O., Yu, L., Thompson, J. M. D., … Stamp, L. K., … Wilcox, P., Grattan, D., … Merriman, T. R. (2018). Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. Advance online publication. doi: 10.1007/s00125-018-4623-1

Wright, D. F. B., Dalbeth, N., Phipps-Green, A. J., Merriman, T. R., Barclay, M. L., Drake, J., … Stamp, L. K. (2018). The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. British Journal of Clinical Pharmacology, 84(5), 937-943. doi: 10.1111/bcp.13516

Stamp, L. K., & Barclay, M. L. (2018). How to prevent allopurinol hypersensitivity reactions? Rheumatology. Advance online publication. doi: 10.1093/rheumatology/kex422

Barclay, M. L., & Stamp, L. K. (2018). Vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease [Invited]. Alimentary Pharmacology & Therapeutics, 47(4), 535-536. doi: 10.1111/apt.14465

Chapter in Book - Research

Dalbeth, N., & Stamp, L. K. (2012). Xanthine oxidase inhibitor treatment of hyperuricemia. In R. Terkeltaub (Ed.), Gout and other crystal arthropathies. (pp. 154-173). Philadelphia, PA: Saunders. doi: 10.1016/B978-1-4377-2864-4.10039-9

Stamp, L. K., & Cleland, L. G. (2008). Foods and rheumatological diseases. In D. D. Metcalfe, H. A. Sampson & R. A. Simon (Eds.), Food allergy: Adverse reactions to foods and food additives. (4th ed.) (pp. 563-574). Malden, MA: Blackwell.

Stamp, L. (2008). Gout. In W. Horobin (Ed.), Diseases and disorders: Emphysema-Obesity (Vol. 2). (pp. 385). Tarrytown, NY: Marshall Cavendish.

Stamp, L. K., & Cleland, L. G. (2008). Rheumatoid arthritis. In L. U. Thompson & W. E. Ward (Eds.), Optimizing women's health through nutrition. (pp. 279-320). Boca Raton, FL: CRC Press.

^ Top of page

Journal - Research Article

Ton, K. N., Cree, S. L., Gronert-Sum, S. J., Merriman, T. R., Stamp, L. K., & Kennedy, M. A. (2018). Multiplexed nanopore sequencing of HLA-B locus in Māori and Pacific Island samples. Frontiers in Genetics. Advance online publication. doi: 10.3389/fgene.2018.00152

Wright, D. F. B., Dalbeth, N., Phipps-Green, A. J., Merriman, T. R., Barclay, M. L., Drake, J., … Stamp, L. K. (2018). The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. British Journal of Clinical Pharmacology, 84(5), 937-943. doi: 10.1111/bcp.13516

Krishnan, M., Major, T. J., Topless, R. K., Dewes, O., Yu, L., Thompson, J. M. D., … Stamp, L. K., … Wilcox, P., Grattan, D., … Merriman, T. R. (2018). Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. Advance online publication. doi: 10.1007/s00125-018-4623-1

Aimer, P., Treharne, G. J., Stebbings, S., Frampton, C., Cameron, V., Kirby, S., & Stamp, L. K. (2017). Efficacy of a rheumatoid arthritis-specific smoking cessation programme: A pilot randomized controlled trial. Arthritis Care & Research, 69(1), 28-37. doi: 10.1002/acr.22960

Muniraj, N., Stamp, L. K., Badiei, A., Hegde, A., Cameron, V., & Bhatia, M. (2017). Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease. International Journal of Rheumatic Diseases, 20(2), 182-189. doi: 10.1111/1756-185x.12472

Ogdie, A., Taylor, W. J., Neogi, T., Fransen, J., Jansen, T. L., Schumacher, H. R., … Stamp, L. K., … Dalbeth, N. (2017). Performance of ultrasound in the diagnosis of gout in a multicenter study: Comparison with monosodium urate monohydrate crystal analysis as the gold standard. Arthritis & Rheumatology, 69(2), 429-438. doi: 10.1002/art.39959

Kannangara, D. R. W., Graham, G. G., Wright, D. F. B., Stocker, S. L., Portek, I., Pile, K. D., Barclay, M. L., … Stamp, L. K., & Day, R. O. (2017). Individualising the dose of allopurinol in patients with gout. British Journal of Clinical Pharmacology, 83(9), 2015-2026. doi: 10.1111/bcp.13307

Tanner, C., Boocock, J., Stahl, E. A., Dobbyn, A., Mandal, A. K., Cadzow, M., Phipps-Green, A. J., Topless, R. K., … Stamp, L. K., … Merriman, T. R. (2017). Population specific resequencing associates the ATP binding cassette subfamily C member 4 (ABCC4) gene with gout in New Zealand Māori and Pacific men. Arthritis & Rheumatology, 69(7), 1461-1469. doi: 10.1002/art.40110

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: A post hoc analysis of a randomized controlled trial. Arthritis Research & Therapy, 19(1), 283. doi: 10.1186/s13075-017-1491-x

Houlder, E. L., Millier, M. J., Highton, J., Gwynne-Jones, D., Stamp, L. K., & Hessian, P. A. (2017). Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clinical & Experimental Rheumatology, 35(6), 943-947.

Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Annals of the Rheumatic Diseases, 76(9), 1522-1528. doi: 10.1136/annrheumdis-2016-210872

Dalbeth, N., Allan, J., Gamble, G. D., Phipps-Green, A., Flynn, T. J., Mihov, B., … Stamp, L. K., & Merriman, T. R. (2017). Influence of genetic variants on renal uric acid handling in response to frusemide: An acute intervention study. RMD Open, 3(1), e000424. doi: 10.1136/rmdopen-2016-000424

Wright, S., Chapman, P. T., Frampton, C., O'Donnell, J. L., Raja, R., & Stamp, L. K. (2017). Management of gout in a hospital setting: A lost opportunity. Journal of Rheumatology. Advance online publication. doi: 10.3899/jrheum.170387

Rasheed, H., Stamp, L. K., Dalbeth, N., & Merriman, T. R. (2017). Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Research & Therapy, 19, 161. doi: 10.1186/s13075-017-1369-y

Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A., … Stamp, L., … on behalf of the EUSTAR group. (2017). Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases. Advance online publication. doi: 10.1136/annrheumdis-2017-211448

McQueen, F. M., Chapman, P., Pollock, T., D’Souza, D., Lee, A. C., Dalbeth, N., Stamp, L., … Doyle, A. (2017). Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis. Arthritis Research & Therapy, 19, 241. doi: 10.1186/s13075-017-1433-7

Cleophas, M. C., Joosten, L. A., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017). ABCG2 polymorphisms in gout: Insights into disease susceptibility and treatment approaches. Pharmacogenomics & Personalized Medicine, 10, 129-142. doi: 10.2147/pgpm.s105854

Farquhar, H. J., McGettigan, B., Chapman, P. T., O'Donnell, J. L., Frampton, C., & Stamp, L. K. (2017). Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake. Internal Medicine Journal, 47(1), 57-61. doi: 10.1111/imj.13246

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R. B., & Stamp, L. K. (2017). Fructose malabsorption in people with and without gout: A case-control study. Seminars in Arthritis & Rheumatism, 47(2), 257-263. doi: 10.1016/j.semarthrit.2017.03.018

Dalbeth, N., Pool, B., Chhana, A., Lin, J.-M., Tay, M. L., Tan, P., … Stamp, L. K., & Cornish, J. (2017). Lack of evidence that soluble urate directly influences bone remodelling: A laboratory and clinical study. Calcified Tissue International. Advance online publication. doi: 10.1007/s00223-017-0328-6

Gosling, A. L., Boocock, J., Dalbeth, N., Harré Hindmarsh, J., Stamp, L. K., Stahl, E. A., … Matisoo-Smith, E. A., & Merriman, T. R. (2017). Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand. Annals of the Rheumatic Diseases. Advance online publication. doi: 10.1136/annrheumdis-2017-212416

He, W., Phipps-Green, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2017). Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Research & Therapy, 19(1), 43. doi: 10.1186/s13075-017-1254-8

Stamp, L. K., Haslett, J., Chapman, P., O'Donnell, J., Raja, R., Rothwell, A., Frampton, C., & Hooper, G. (2017). Rates of joint replacement surgery in New Zealand, 1999-2015: A comparison of rheumatoid arthritis and osteoarthritis. Journal of Rheumatology. Advance online publication. doi: 10.3899/jrheum.170551

Stamp, L. K., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., Lassere, M., & Christensen, R. (2017). Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirements. Journal of Rheumatology, 45(3), 170911. doi: 10.3899/jrheum.170911

Stamp, L., & Dalbeth, N. (2017). Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. Seminars in Arthritis & Rheumatism, 46(4), 457-464. doi: 10.1016/j.semarthrit.2016.07.015

Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., Toyoda, Y., … Stamp, L. K., … Merriman, T. R., & Matsuo, H. (2017). GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Annals of the Rheumatic Diseases, 76(5), 869-877. doi: 10.1136/annrheumdis-2016-209632

Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., & Treharne, G. J. (2017). Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal Care. Advance online publication. doi: 10.1002/msc.1209

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). Allopurinol dose escalation to achieve serum urate below 6 mg/dL: An open-label extension study. Annals of the Rheumatic Diseases, 76(12), 2065-2070. doi: 10.1136/annrheumdis-2017-211873

Wright, D. F. B., Doogue, M. P., Barclay, M. L., Chapman, P. T., Cross, N. B., Irvine, J. H., & Stamp, L. K. (2017). A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis. European Journal of Clinical Pharmacology, 73, 71-78. doi: 10.1007/s00228-016-2133-y

Vazirpanah, N., Kienhorst, L. B. E., Van Lochem, E., Wichers, C., Rossato, M., Shiels, P. G., … Stamp, L. K., Merriman, T. R., … Broen, J. C. A. (2017). Patients with gout have short telomeres compared with healthy participants: Association of telomere length with flare frequency and cardiovascular disease in gout. Annals of the Rheumatic Diseases. Advance online publication. doi: 10.1136/annrheumdis-2016-210538

Millier, M. J., Stamp, L. K., & Hessian, P. A. (2017). Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Scientific Reports, 7, 17235 . doi: 10.1038/s41598-017-17619-0

Fanning, N., Merriman, T. R., Dalbeth, N., & Stamp, L. K. (2017). An association of smoking with serum urate and gout: A health paradox. Seminars in Arthritis & Rheumatism. Advance online publication. doi: 10.1016/j.semarthrit.2017.11.004

Roberts, R. L., Wallace, M. C., Phipps-Green, A. J., Topless, R., Drake, J. M., Tan, P., … Merriman, T. R., & Stamp, L. K. (2017). ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout. Pharmacogenomics Journal, 17, 201-203. doi: 10.1038/tpj.2015.101

Treharne, G. J., Richardson, A. C., Neha, T., Fanning, N., Janes, R., Hudson, B., … Pitama, S., & Stamp, L. K. (2017). Education preferences of people with gout: Exploring differences between indigenous and non-indigenous peoples from rural and urban locations. Arthritis Care & Research. Advance online publication. doi: 10.1002/acr.23272

Gath, M. E., Stamp, L. K., Aimer, P., Stebbings, S., & Treharne, G. J. (2017). Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators. Musculoskeletal Care. Advance online publication. doi: 10.1002/msc.1227

Rasheed, H., McKinney, C., Stamp, L. K., Dalbeth, N., Topless, R. K., Day, R., … Merriman, T. R. (2016). The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets. PLoS ONE, 11(1), e0147939. doi: 10.1371/journal.pone.0147939

Bayat, S., Aati, O., Rech, J., Sapsford, M., Cavallaro, A., Lell, M., … Stamp, L. K., … Dalbeth, N. (2016). Development of a dual energy computed tomography scoring system for measurement of urate deposition in gout. Arthritis Care & Research, 68(6), 769-775. doi: 10.1002/acr.22754

Wright, D. F. B., Duffull, S. B., Merriman, T. R., Dalbeth, N., Barclay, M. L., & Stamp, L. K. (2016). Predicting allopurinol response in patients with gout. British Journal of Clinical Pharmacology, 81(2), 277-289. doi: 10.1111/bcp.12799

Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016). Gout. Lancet, 388(10055), 2039-2052. doi: 10.1016/S0140-6736(16)00346-9

Stamp, L. K., Haslett, J., Frampton, C., White, D., Gardner, D., Stebbings, S., … Grainger, R., … Dalbeth, N. (2016). The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. Internal Medicine Journal, 46(9), 1075-1080. doi: 10.1111/imj.13173

Taylor, W. J., Fransen, J., Dalbeth, N., Neogi, T., Schumacher, H. R., Brown, M., … Stamp, L. K., … Jansen, T. L. (2016). Performance of classification criteria for gout in early and established disease. Annals of the Rheumatic Diseases, 75, 178-182. doi: 10.1136/annrheumdis-2014-206364

Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., Croft, S., & Treharne, G. J. (2016). Developing a tailored smoking cessation intervention for rheumatoid arthritis patients. Musculoskeletal Care, 14(1), 2-14. doi: 10.1002/msc.1106

Dalbeth, N., Schumacher, H. R., Fransen, J., Neogi, T., Jansen, T. L., Brown, M., … Stamp, L. K., … Taylor, W. J. (2016). Survey definitions of gout for epidemiological studies: Comparison with crystal identification as the gold standard. Arthritis Care & Research, 68(12), 1894-1898. doi: 10.1002/acr.22896

Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M. D., Hill, C., Lester, S., … van Rij, A., Jones, G. T., McCormick, S. P., Harrison, A. A., Stamp, L. K., … Merriman, T. R. (2016). Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology, 55(8), 1421-1430. doi: 10.1093/rheumatology/kew057

Phipps-Green, A. J., Merriman, M. E., Topless, R., Altaf, S., Montgomery, G. W., Franklin, C., Jones, G. T., van Rij, A. M., … Stamp, L. K., … Merriman, T. R. (2016). Twenty-eight loci that influence serum urate levels: Analysis of association with gout. Annals of the Rheumatic Diseases, 75, 124-130. doi: 10.1136/annrheumdis-2014-205877

Towiwat, P., Doyle, A. J., Gamble, G. D., Tan, P., Aati, O., Horne, A., Stamp, L. K., & Dalbeth, N. (2016). Urate crystal deposition and bone erosion in gout: 'Inside-out' or 'outside-in'? A dual-energy computed tomography study. Arthritis Research & Therapy, 18(1), 208. doi: 10.1186/s13075-016-1105-z

Fatima, T., Altaf, S., Phipps-Green, A., Topless, R., Flynn, T. J., Stamp, L. K., … Merriman, T. R. (2016). Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout. Rheumatology International, 36(2), 255-261. doi: 10.1007/s00296-015-3370-6

Stamp, L. K., Chapman, P. T., & Palmer, S. C. (2016). Allopurinol and kidney function: An update. Joint Bone Spine, 83, 19-24. doi: 10.1016/j.jbspin.2015.03.013

Kannangara, D. R. W., Phipps-Green, A. J., Dalbeth, N., Stamp, L. K., Williams, K. M., Graham, G. G., … Merriman, T. R. (2016). Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Annals of the Rheumatic Diseases, 75, 1363-1366. doi: 10.1136/annrheumdis-2015-208111

Stamp, L. K., Day, R. O., & Yun, J. (2016). Allopurinol hypersensitivity: Investigating the cause and minimizing the risk. Nature Reviews Rheumatology, 12, 235-242. doi: 10.1038/nrrheum.2015.132

Hock, B. D., Stamp, L. K., Hayman, M. W., Keating, P. E., Helms, E. T. J., & Barclay, M. L. (2016). Development of an ELISA-based competitive binding assay for the analysis of drug concentration and anti-drug antibody levels in patients receiving adalimumab or infliximab. Therapeutic Drug Monitoring, 38(1), 32-41. doi: 10.1097/ftd.0000000000000229

Mitnala, S., Phipps-Green, A., Franklin, C., Horne, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2016). Clinical and genetic features of diuretic-associated gout: A case-control study. Rheumatology, 55(7), 1172-1176. doi: 10.1093/rheumatology/kew018

Cadzow, M., Merriman, T. R., Boocock, J., Dalbeth, N., Stamp, L. K., Black, M. A., … Wilcox, P. L. (2016). Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A. BMC Medical Genetics, 17, 80. doi: 10.1186/s12881-016-0341-z

Taylor, W. J., Fransen, J., Dalbeth, N., Neogi, T., Schumacher, H. R., Brown, M., … Stamp, L. K., … Jansen, T. L. (2016). Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated. Journal of Rheumatology, 43(1), 150-153. doi: 10.3899/jrheum.150684

Dalbeth, N., Phipps-Green, A., House, M. E., Gamble, G. D., Horne, A., Stamp, L. K., & Merriman, T. R. (2015). Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. Arthritis Research & Therapy, 17(1), 263. doi: 10.1186/s13075-015-0781-4

Huffman, J. E., Albrecht, E., Teumer, A., Mangino, M., Kapur, K., Johnson, T., … Phipps-Green, A., … Stamp, L., & . . . (2015). Modulation of genetic associations with serum urate levels by body-mass-index in humans. PLoS ONE, 10(3), e0119752. doi: 10.1371/journal.pone.0119752

Roberts, R. L., & Stamp, L. K. (2015). Pharmacogenetic considerations in the treatment of gout. Pharmacogenomics, 16(6), 619-629. doi: 10.2217/pgs.15.16

Roberts, R. L., Wallace, M. C., Harrison, A., Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2015). A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout. Pharmacogenetics & Genomics, 25(8), 412-415. doi: 10.1097/fpc.0000000000000147

Pan, S., Korell, J., Stamp, L. K., & Duffull, S. B. (2015). Simplification of a pharmacokinetic model for red blood cell methotrexate disposition. European Journal of Clinical Pharmacology, 71(12), 1509-1516. doi: 10.1007/s00228-015-1951-7

Aimer, P., Stamp, L., Stebbings, S., Valentino, N., Cameron, V., & Treharne, G. J. (2015). Identifying barriers to smoking cessation in rheumatoid arthritis. Arthritis Care & Research, 67(5), 607-615. doi: 10.1002/acr.22503

Kienhorst, L. B. E., van Lochem, E., Kievit, W., Dalbeth, N., Merriman, M. E., Phipps-Green, A., … Stamp, L. K., … Merriman, T. R., … Radstake, T. R. D. J. (2015). Gout is a chronic inflammatory disease in which high levels of interleukin 8 (CXCL8), myeloid-related protein 8/myeloid-related protein14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis & Rheumatology, 67(12), 3303-3313. doi: 10.1002/art.39318

Johnston, M. E., Treharne, G. J., Chapman, P. T., & Stamp, L. K. (2015). Patient information about gout: An international review of existing educational resources. Journal of Rheumatology, 42(6), 975-978. doi: 10.3899/jrheum.141442

Taylor, W. J., Fransen, J., Jansen, T. L., Dalbeth, N., Schumacher, H. R., Brown, M., … Stamp, L. K., … Neogi, T. (2015). Study for updated gout classification criteria: Identification of features to classify gout. Arthritis Care & Research, 67(9), 1304-1315. doi: 10.1002/acr.22585

Aati, O., Taylor, W. J., Siegert, R. J., Horne, A., House, M. E., Tan, P., … Stamp, L. K., & Dalbeth, N. (2015). Development of a patient-reported outcome measure of tophus burden: The Tophus Impact Questionnaire (TIQ-20). Annals of the Rheumatic Diseases, 74, 2144-2150. doi: 10.1136/annrheumdis-2014-205671

Topless, R. K., Flynn, T. J., Cadzow, M., Stamp, L. K., Dalbeth, N., Black, M. A., & Merriman, T. R. (2015). Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women. Frontiers in Genetics, 6, 313. doi: 10.3389/fgene.2015.00313

Stamp, L. K., Chapman, P. T., Francis, J., Beckert, L., Frampton, C., Watts, R. A., & O'Donnell, J. L. (2015). Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand. Arthritis Research & Therapy, 17, 333. doi: 10.1186/s13075-015-0852-6

Murphy, R., Thornley, S., de Zoysa, J., Stamp, L. K., Dalbeth, N., & Merriman, T. R. (2015). Sugar sweetened beverage consumption among adults with gout or type 2 diabetes. PLoS ONE, 10(5), e0125543. doi: 10.1371/journal.pone.0125543

Flynn, T. J., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harré Hindmarsh, J., Todd, A. S., Walker, R. J., Topless, R., & Merriman, T. R. (2015). Positive association of tomato consumption with serum urate: Support for tomato consumption as an anecdotal trigger of gout flares. BMC Musculoskeletal Disorders, 16, 196. doi: 10.1186/s12891-015-0661-8

McKinney, C., Stamp, L. K., Dalbeth, N., Topless, R. K., Day, R. O., Kannangara, D. R. W., … Merriman, T. R. (2015). Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Research & Therapy, 17, 288. doi: 10.1186/s13075-015-0802-3

Kennedy, N., Chambers, S. T., Nolan, I., Gallagher, K., Werno, A., Browne, M., & Stamp, L. K. (2015). Native joint septic arthritis: Epidemiology, clinical features, and microbiological causes in a New Zealand population. Journal of Rheumatology, 42(12), 2392-2397. doi: 10.3899/jrheum.150434

Stamp, L. K., & Chapman, P. T. (2014). Urate-lowering therapy: Current options and future prospects for elderly patients with gout. Drugs & Aging, 31(11), 777-786. doi: 10.1007/s40266-014-0214-0

Stamp, L. K., Turner, R., Khalilova, I. S., Zhang, M., Drake, J., Forbes, L. V., & Kettle, A. J. (2014). Myeloperoxidase and oxidation of uric acid in gout: Implications for the clinical consequences of hyperuricaemia. Rheumatology, 53(11), 1958-1965. doi: 10.1093/rheumatology/keu218

Korell, J., Duffull, S. B., Dalrymple, J. M., Drake, J., Zhang, M., Barclay, M. L., & Stamp, L. K. (2014). Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types. British Journal of Clinical Pharmacology, 77(3), 493-497. doi: 10.1111/bcp.12209

Rasheed, H., Hsu, A., Dalbeth, N., Stamp, L. K., McCormick, S., & Merriman, T. R. (2014). The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout. Arthritis Research & Therapy, 16(6), 495.

Batt, C., Phipps-Green, A. J., Black, M. A., Cadzow, M., Merriman, M. E., Topless, R., … Harrison, A., Highton, J., … Stamp, L., … Merriman, T. R. (2014). Sugar-sweetened beverage consumption: A risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Annals of the Rheumatic Diseases, 73(12), 2101-2106. doi: 10.1136/annrheumdis-2013-203600

Stamp, L. K., & Barclay, M. (2014). Therapeutic drug monitoring in rheumatic diseases: Utile or futile? Rheumatology, 53(6), 988-997. doi: 10.1093/rheumatology/ket355

Roberts, R. L., Wallace, M. C., Wright, D. F. B., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harrison, A. A., Black, M. A., & Merriman, T. R. (2014). Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. Joint Bone Spine, 81(2), 160-163. doi: 10.1016/j.jbspin.2013.07.006

Knake, C., Stamp, L., & Bahn, A. (2014). Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment. Biochemical & Biophysical Research Communications, 452, 157-162. doi: 10.1016/j.bbrc.2014.08.068

Pan, S., Stamp, L. K., Duffull, S. B., Barclay, M. L., Dalrymple, J. M., Drake, J., Zhang, M., & Korell, J. (2014). Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. Clinical Pharmacokinetics, 53(12), 1161-1170. doi: 10.1007/s40262-014-0179-5

Stamp, L. K., Merriman, T. R., Barclay, M. L., Singh, J. A., Roberts, R. L., Wright, D. F. B., & Dalbeth, N. (2014). Impaired response or insufficient dosage? Examining the potential causes of ”inadequate response” to allopurinol in the treatment of gout. Seminars in Arthritis & Rheumatism, 44(2), 170-174. doi: 10.1016/j.semarthrit.2014.05.007

Stamp, L. K. (2013). Safety profile of anti-gout agents: An update. Current Opinion in Rheumatology, 26(2), 162-168. doi: 10.1097/bor.0000000000000031

Stamp, L. K., O'Donnell, J. L., Frampton, C., Drake, J. M., Zhang, M., & Chapman, P. T. (2013). Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: A pilot randomized controlled trial. Arthritis & Rheumatism, 65(6), 1636-1642. doi: 10.1002/art.37925

Stamp, L. K., Hazlett, J., Highton, J., & Hessian, P. A. (2013). Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue. Journal of Rheumatology, 40(9), 1519-1522. doi: 10.3899/jrheum.130066

Stamp, L. K., & Chapman, P. T. (2013). Gout and its comorbidities: Implications for therapy. Rheumatology, 52(1), 34-44. doi: 10.1093/rheumatology/kes211

Flynn, T. J., Phipps-Green, A., Hollis-Moffatt, J. E., Merriman, M. E., Topless, R., Montgomery, G., … Stamp, L. K., … Merriman, T. R. (2013). Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Research & Therapy, 15, R220. doi: 10.1186/ar4417

Korell, J., Stamp, L. K., Barclay, M. L., Dalrymple, J. M., Drake, J., Zhang, M., & Duffull, S. B. (2013). A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells. Clinical Pharmacokinetics, 52(6), 475-485. doi: 10.1007/s40262-013-0052-y

Wright, D. F. B., Stamp, L. K., Merriman, T. R., Barclay, M. L., Duffull, S. B., & Holford, N. H. G. (2013). The population pharmacokinetics of allopurinol and oxypurinol in patients with gout. European Journal of Clinical Pharmacology, 69(7), 1411-1421. doi: 10.1007/s00228-013-1478-8

Rasheed, H., Phipps-Green, A., Topless, R., Hollis-Moffatt, J. E., Harré Hindmarsh, J., Franklin, C., … Stamp, L. K., & Merriman, T. R. (2013). Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Research & Therapy, 15, R177. doi: 10.1186/ar4366

Khan, E. A. R., Stamp, L. K., O'Donnell, J. L., & Chapman, P. T. (2013). Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999–2008. International Journal of Rheumatic Diseases, 16(1), 19-23. doi: 10.1111/1756-185x.12008

Prowse, R. L., Dalbeth, N., Kavanaugh, A., Adebajo, A. O., Gaffo, A. L., Terkeltaub, R., … Stamp, L. K., … Chapman, P., … Grainger, R., … Taylor, W. J. (2013). A Delphi exercise to identify characteristic features of gout: Opinions from patients and physicians, the first stage in developing new classification criteria. Journal of Rheumatology, 40(4), 498-505. doi: 10.3899/jrheum.121037

Stamp, L. K., Wells, J. E., Pitama, S., Faatoese, A., Doughty, R. N., Whalley, G., Richards, A. M., & Cameron, V. A. (2013). Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities. Internal Medicine Journal, 43(6), 678-684. doi: 10.1111/imj.12062

Roberts, R. L., Wallace, M. C., Jones, G. T., van Rij, A. M., Merriman, T. R., Harrison, A., … Stamp, L. K., … Highton, J., & Stebbings, S. M. (2013). Prevalence of HLA-B27 in the New Zealand population: Effect of age and ethnicity. Arthritis Research & Therapy, 15, R158. doi: 10.1186/ar4341

Stamp, L. K., & Chapman, P. T. (2012). Gout and organ transplantation. Current Rheumatology Reports, 14(2), 165-172. doi: 10.1007/s11926-012-0235-9

Stamp, L. K., Barclay, M. L., O'Donnell, J. L., Zhang, M., Drake, J., Frampton, C., & Chapman, P. T. (2012). Furosemide increases plasma oxypurinol without lowering serum urate—a complex drug interaction: Implications for clinical practice. Rheumatology, 51(9), 1670-1676. doi: 10.1093/rheumatology/kes091

Kazantseva, M. G., Highton, J., Stamp, L. K., & Hessian, P. A. (2012). Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis. Arthritis Research & Therapy, 14, R208. doi: 10.1186/ar4046

Chen-Xu, M., Topless, R., McKinney, C., Merriman, M. E., Phipps-Green, A., Dalbeth, N., … Harrison, A. A., Highton, J., … van Rij, A., Jones, G. T., … Stamp, L. K., … Merriman, T. R. (2012). Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Annals of the Rheumatic Diseases, 71(1), 155-157. doi: 10.1136/annrheumdis-2011-200591

More publications...